Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase
about
Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activityProstate-specific membrane antigen as a target for cancer imaging and therapyChemoaffinity capture of pre-targeted prostate cancer cells with magnetic beadsReal-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer.Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate CancerThe cloning and characterization of a second brain enzyme with NAAG peptidase activityAdvances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide familyDisplay technologies: application for the discovery of drug and gene delivery agents.The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen.177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice.Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling.A targeted low molecular weight near-infrared fluorescent probe for prostate cancer.Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.PSMA-targeted SPECT agents: mode of binding effect on in vitro performance.Endosomal pH-Responsive Polymer-Based Dual-Ligand-Modified Micellar Nanoparticles for Tumor Targeted Delivery and Facilitated Intracellular Release of Paclitaxel.Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen.Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigenInduction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.Substrate specificity of prostate-specific membrane antigen.Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate.Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen.Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophreniaPromoter analysis of human glutamate carboxypeptidase II.Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cellsSynthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging.Pharmacokinetic and Biodistribution Assessment of a Near Infrared-Labeled PSMA-Specific Small Molecule in Tumor-Bearing Mice.68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling.Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer.Development of a Single Stranded DNA Aptamer as a Molecular Probe for LNCap Cells Using Cell-SELEX.Chemically synthesized molecules with the targeting and effector functions of antibodies.PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking.A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent.Flow cytometric detection of prostate tumor cells using chemoaffinity labels.Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer.Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.Mice lacking glutamate carboxypeptidase II develop normally, but are less susceptible to traumatic brain injury.Evaluation of prostate-specific membrane antigen as an imaging reporter.A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer.
P2860
Q24646415-BCBFE20B-B4AE-4721-AC68-C44D56C0DD69Q26799439-82CF8156-126B-4018-9B3F-E3C899BC2658Q26861322-60E34D4A-A13E-4077-80BC-3B4F59671209Q27346788-1BBB3AD1-FEA2-484D-ABAD-68514CCCAD75Q27705945-BDDAAC46-E8B1-4013-A82D-78AD8F634CDDQ28589768-276C6F72-21D4-47AD-B964-53CE231C2785Q30465259-3D0F8665-BCD5-4B61-8325-87B7E753813FQ33264491-E30C8252-2970-4C84-ACF3-C93A28C9328CQ33299095-B6B1E5E9-946C-4CCB-9238-BF604C19592AQ33821017-7DB25EDC-6151-454E-A5F9-7D20F5776703Q35413768-82AA8C8C-3960-48AC-A1AF-85066878F30AQ35446801-A83C72BA-1AE7-4811-B87D-F9759194575CQ35446818-324AA142-A012-4F29-A098-E5C15F57505CQ35552454-392971F7-3C35-4CC0-A9E5-55FF9D9F1DEFQ35560114-9EF070EC-9F1D-475D-9D4C-25E8816EE69EQ35758285-564EFD1E-B732-4382-B957-7A25CBDD3DABQ35926706-CEB2DC52-A981-4DE4-A49D-D2DE9137CDE8Q35948223-448BA711-ADF4-4496-8111-9C9182345E8CQ36054736-4F311056-6BCC-434C-B4B2-614422B1DBAEQ36477594-05AC89BD-5038-4793-929A-FC8C8CB8A22EQ36478758-4466D53A-1A83-4D2C-83E2-F2FCF8FB032AQ36501550-72D053AD-0931-4907-9BA2-EF6509CA8F26Q36621035-7CCEDF69-0E0A-47EA-A7AD-3F7281FCA050Q37251428-C9A45A2F-3E8E-4894-95C5-44AA31D05975Q37591940-AE11951E-6254-4B4C-81E1-18B8FD337696Q37662752-12ED3703-2127-494D-B667-5A1BEAA26A6FQ37719087-94FA2C7B-9042-416C-B70B-01D3910A1ABFQ38707752-ACE38D20-86E1-45ED-A727-5D0337C0D0A4Q38820744-3FDDD268-D215-40CC-ACC2-BD626C3646EFQ38827635-376D2B83-4189-49FB-BFE6-DA0399753694Q38928032-79A3938D-B189-4C64-8336-FBAA29E9ED6AQ38938291-8F7B9D4A-A036-409E-BC7A-72E5ACF93894Q39336427-A3967D66-3AB6-4CA1-8FE2-CF0AB7EFADA0Q39679963-349A2BA2-8C9C-44A3-A6AE-530F8A31BC98Q39808317-84659347-A82F-4081-9B6E-77E974174443Q40371330-E8805425-5A3A-45DC-A167-8E5E39969EA3Q40539364-8D08FE7E-9663-4833-96A2-D49F3F9D5EBFQ41074666-9F09ABEA-787D-48E2-8636-392AE9E3AAACQ41462083-AA261CBF-F439-46FE-98D9-0E629ADC8D05Q41600550-1DC2F7E7-87DE-4AEC-A9BC-7F565B15257D
P2860
Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase
description
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Februar 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/02/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/02/01)
@nl
наукова стаття, опублікована в лютому 2001
@uk
مقالة علمية (نشرت في فبراير 2001)
@ar
name
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@ast
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@en
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@nl
type
label
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@ast
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@en
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@nl
prefLabel
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@ast
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@en
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@nl
P2093
P356
P1433
P1476
Cloning, expression, genomic l ...... gen/NAALADase/folate hydrolase
@en
P2093
D. J. Bacich
J. T. Pinto
W. D. Heston
W. P. Tong
P2888
P304
P356
10.1007/S003350010240
P577
2001-02-01T00:00:00Z